IVOG - Vanguard S&P Mid-Cap 400 Growth ETF
| Assets | $944.79M |
| NAV | $203.18 |
| Expense Ratio | 0.15% |
| PE Ratio | 32.20 |
| Beta (5Y) | 1.11 |
| Dividend (ttm) | $1.32 |
| Dividend Yield | 0.65% |
| Ex-Dividend Date | Dec 22, 2020 |
| 1-Year Return | - |
| Trading Day | April 19 |
| Last Price | $201.18 |
| Previous Close | $203.26 |
| Change ($) | -2.08 |
| Change (%) | -1.02% |
| Day's Open | 202.59 |
| Day's Range | 200.48 - 202.72 |
| Day's Volume | 6,540 |
| 52-Week Range | 113.51 - 203.39 |
Fund Description
The investment seeks to track the performance of a benchmark index that measures the investment return of mid-capitalization growth stocks in the United States. The fund employs an indexing investment approach designed to track the performance of the S&P MidCap 400® Growth Index, which represents the growth companies, as determined by the index sponsor, of the S&P MidCap 400 Index. The Advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
| Asset Class Equity | Sector Mid Cap |
| Region North America | Inception Date Sep 9, 2010 |
| Exchange NYSEARCA | Ticker Symbol IVOG |
| Index Tracked S&P Mid-Cap 400 Growth Index | |
Top 10 Holdings
12.86% of assets| Name | Symbol | Weight |
|---|---|---|
| SolarEdge Technologies | SEDG | 1.39% |
| Bio-Techne | TECH | 1.39% |
| Cognex | CGNX | 1.37% |
| PTC Inc. | PTC | 1.35% |
| Charles River Laboratories | CRL | 1.35% |
| Fair Isaac | FICO | 1.33% |
| Williams-Sonoma | WSM | 1.28% |
| Cree, Inc. | CREE | 1.16% |
| Graco | GGG | 1.13% |
| Darling Ingredients | DAR | 1.12% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 22, 2020 | $1.32 | Dec 28, 2020 |
| Dec 16, 2019 | $1.722 | Dec 19, 2019 |
| Dec 13, 2018 | $1.194 | Dec 18, 2018 |
| Dec 19, 2017 | $1.2364 | Dec 22, 2017 |
| Dec 20, 2016 | $1.158 | Dec 27, 2016 |
| Dec 17, 2015 | $1.034 | Dec 23, 2015 |
This Vanguard S&P Mid-Cap 400 Growth ETF (IVOG) has hit a new 52-week high. Are more gains in store?
Investors seeking to capitalize on strong fundamentals but worried about trade war should consider mid-cap stocks in the basket form.
PTH and IVOG saw massive trading volumes in yesterday trading session.